News | Cath Lab | October 09, 2015

Cardinal Health and Cordis Debut Combined Product Offerings at TCT 2015

Cardiovascular portfolio from Cardinal Health is significantly expanded with recent completion of the Cordis acquisition

October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiovascular space including the latest innovations from Cordisduring the 27th Transcatheter Cardiovascular Therapeutics (TCT) conference Oct. 11-15, 2015 in San Francisco. Attendees will gain insight to the Cardinal Health and Cordis comprehensive offering of daily-use products; reliable, trackable inventory and logistics, and deep analytic capabilities. This multi-dimensional set of solutions will become increasingly important with emerging value-based payment models.

“This acquisition brings together two important leaders in the healthcare industry, creating a combined offering in the cardiovascular and medical device space that will ensure greater access to quality products and services worldwide,” said David Wilson, president of Cordis, a Cardinal Health company. “By leveraging Cardinal Health’s business and operational expertise and Cordis’ deep experience in product innovation, we are very well positioned to meet the evolving needs of our customers and their patients.”

Cardinal Health will feature several new technologies and solutions at TCT, including:

•    The new Paxwire Occlusion Balloon System, which is indicated for temporary flow occlusion in the iliofemoral artery, is designed to provide bleeding control for complications management of mid- and large-bore procedures above 8F. The compliant balloon, integrated into a 0.035" wire, can be inserted through the procedural sheath and quickly inflated to provide occlusion while the procedural sheath is removed, and control bleeding while repair is performed.  The Paxwire system will be available for commercial release later this year. 

•    The Cordis Crossing Portfolio reduces the complexity of challenging cases and provides a comprehensive crossing solution of specialty and workhorse devices. The new Elitecross Support Catheter family, available in the United States and Europe, provides unparalleled support and pushability to help get to and through complex lesions. The catheter features a braided shaft, tapered tip, lubricious hydrophilic coating and ultra, low-friction inner lumen to enhance trackability over the guidewire. The Elitecross Support Catheter is designed to provide additional support to the distal portion of diagnostic or interventional devices, and is compatible with the Frontrunner XP CTO Catheter, as well as other ancillary devices.

•    The radio frequency identification (RFID) -enhanced supply chain management technology is designed to reinvent internal supply chains and enhance inventory management, streamline clinical workflows, improve usage capture and gain alignment among various departments. Through the utilization of RFID technology, cloud-based automation and data analytics, Cardinal Health provides a shared data platform between hospitals and device manufacturers to help solve supply chain management issues and remove waste.

Conference attendees can gain insight on the latest advances in current therapies and clinical research from an expert team representing Medstar Washington Hospital Center as they discuss “Exploring Emerging Trends: Managing Large-Bore Complications and Venous Access Site Closure” in a breakfast symposium on Tuesday, Oct. 13 at 7 a.m. in the Moscone Convention Center, room 121. 

For more information: www.cardinalhealth.com/cardiovascular

Related Content

PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices| August 23, 2017
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology...
CMS Awards New Technology Add-on Payment for Perceval Sutureless Aortic Heart Valve
News | Heart Valve Technology| August 22, 2017
August 22, 2017 — LivaNova PLC announced its Perceval ...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Overlay Init